TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | -1 | -2 | -26 | -15 | -8 | -8 |
| P | %wins | 100 | 50 | 50 | 0 | 50 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/07 11:01 | 11/16/07 | SLXP | Salix Pharmaceuticals Ltd | Health | Drug | Pharmaceutical Preparations | Logan Carolyn J | NC | DO | P,CEO | P.d | 73 | 10.48 | 11 | 7 | 1 | 477 | D | -46 | -24 | -21 | -10 | -19 | -11 | -9 | -9 | 4 | 2 | 12 | -37 | -32 | -11 | |
5/10/06 15:42 | 5/9/06 | SLXP | Salix Pharmaceuticals Ltd | Health | Drug | Pharmaceutical Preparations | Logan Carolyn J | NC | DO | P,CEO | P.d | 99 | 13.23 | 8 | 8 | 3 | 305 | D | -38 | -11 | -25 | -24 | -20 | -7 | -4 | 7 | 2 | -3 | -15 | -15 | 3 | -4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |